Skip to main content
Intermediate Technical IVT

AT/RT

Also written as: AT/RT — Atypical Teratoid/Rhabdoid Tumour

Abbreviation for atypical teratoid/rhabdoid tumour, an aggressive paediatric CNS malignancy defined by SMARCB1/INI1 loss.

Full Definition

AT/RT is the standard abbreviation for atypical teratoid/rhabdoid tumour and is widely used in paediatric neuropathology, neuro-oncology, and clinical trial documentation. The solidus within the abbreviation mirrors the solidus in the full name and must be preserved. Editors must not reformat 'AT/RT' as 'ATRT' or 'AT-RT', as neither variant is accepted in current WHO nomenclature. The abbreviation should be defined at first use in continuous text.

Usage

Usage note: Do not reformat as 'ATRT' or 'AT-RT'. The solidus is mandatory in both the full form and the abbreviation.

In Context

  • "The clinical trial enrolled 12 paediatric patients with AT/RT across five participating centres." — Clinical trial report
  • "Editors should confirm the solidus is preserved in 'AT/RT'; 'ATRT' without the slash is a formatting error." — Manuscript style check

Also known as

atypical teratoid/rhabdoid tumour

Don't confuse with

ETMR rhabdoid tumour of the kidney (RTK)

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON